HSBC Holdings’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

HSBC Holdings’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,640	Closed	-$151K	–	3296
2023 Q4	$151K	Hold	59,640	–	–	﹤0.01%	2531
2023 Q3	$142K	Buy	59,640 +16,141	+37%	+$35.7K	﹤0.01%	2493
2023 Q2	$101K	Sell	43,499 -21,089	-33%	-$59.5K	﹤0.01%	2424
2023 Q1	$159K	Buy	64,588 +12,113	+23%	+$34.7K	﹤0.01%	2433
2022 Q4	$133K	Buy	52,475 +33,414	+175%	+$93.2K	﹤0.01%	2860
2022 Q3	$57K	Buy	+19,061	New	+$80.2K	﹤0.01%	2806

HSBC Holdings's SLGC Position: Q1 2024 in Review

HSBC Holdings sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 59,640 shares — an estimated $151K sold.

HSBC Holdings first reported a position in SLGC in Q3 2022 and held it in 6 quarters. The position peaked at $159K in Q1 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

HSBC Holdings reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
HSBC Holdings sold 59,640 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $151K.
HSBC Holdings first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2022 and held it in 6 quarters.
HSBC Holdings's SomaLogic, Inc. Class A Common Stock position peaked at $159K in Q1 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.